Nid ydym yn gwybod a yw'r ymateb mwyaf diweddar i'r cais hwn yn cynnwys gwybodaeth neuai peidio - os chi ywThomas Harding mewngofnodwch a gadael i bawb wybod.

Urology department: impact of COVID-19 on prostate cancer diagnosis, treatment and support

We're waiting for Thomas Harding to read recent responses and update the status.

Dear Mid and South Essex NHS Foundation Trust,

Prostate Cancer UK are undertaking a Freedom of Information Act (FOI) request of all Trusts, Health Boards and Health and Social Care Trusts, with the aim of assessing the impact of COVID-19 on prostate cancer diagnosis, treatment and support pathways.

Data will be used to identify how we can target future resources to ensure that all patients with suspected prostate cancer have access to pre-biopsy MRI and biopsy, treatment within a safe time period and support, with minimal risk of contracting COVID-19.

We really appreciate your help with this, especially as we understand that there are currently potential limitations on resources. Please pass the below on to your urology department for them to complete. If this is not possible, we would really appreciate your help to provide as much information as you can.

We ask that you please indicate your answer by marking with an “X” next to any answers that apply or by deleting all answers that do not apply. Please avoid answering by italics, underlining or bold, as these do not show up when we process your response.

Yours faithfully,

Thomas Harding (Knowledge Officer, Prostate Cancer UK)

1. Did you suspend your MRI before biopsy service for patients with suspected prostate cancer as a result of the COVID-19 pandemic?
a. Yes
b. No
c. We did not offer MRI before biopsy before the pandemic

2. If yes, have you now resumed MRI before biopsy for patients with suspected prostate cancer?
a. Yes
b. No
c. No, but we refer patients elsewhere (Please state the referral area:)
d. N /A

3. Do you currently use a pre-MRI clinical triage for patients with suspected prostate cancer? By pre-MRI clinical triage, we mean a process, often Clinical Nurse Specialist led, that determines patient suitability for MRI before biopsy
a. Yes
b. No

4. Has your radiology department introduced any new MRI exclusion criteria for patients with suspected prostate cancer as a result of COVID-19?
a. Yes (please specify:)
b. No
c. N/A

5. If yes, do you plan to maintain any of these exclusion criteria once restrictions to limit patients’ COVID-19 risk are lifted?
a. Yes (please specify:)
b. No
c. N/A

6. Did you stop conducting biopsies for patients with suspected prostate cancer as a result of COVID-19 infection risks?
a. Yes
b. No

7. If yes, have you resumed biopsy services for patients with suspected prostate cancer?
a. Yes
b. Yes, but only for a subset of patients (please specify:)
c. No
d. No, but we refer patients elsewhere for prostate biopsy (Please state the referral area:)

8. Do you offer transperineal biopsy under local anaesthetic?
a. Yes
b. No
c. No, but we plan to in future (please specify when if possible:)

9. Following an MRI scan for suspected prostate cancer, what criteria do you use to select patients for biopsy? Please include all that apply:
a. Patients with a PI-RADSs or Likert score of 1 or greater
b. Patients with a PI-RADS or Likert score of 2 or greater
c. Patients with a PI-RADS or Likert score of 3 or greater
d. Patients with a PI-RADS or Likert score of 3 or greater, but only if PI-RADS or Likert score 3 patients have other clinical indications (such as age, ethnicity, PSA density) that make them higher risk
e. Patients with a PI-RADS or Likert score of 4 or greater
f. We do not offer MRI before biopsy
g. We do not currently biopsy patients

10. Did you delay radiotherapy treatment for prostate cancer patients as a result of COVID-19?
a. Yes
b. No
c. Partially (please specify:)
d. N/A (please specify:)

11. If yes, have you cleared your backlog for prostate cancer radiotherapy treatment?
a. Yes
b. No
c. N/A – We did not delay prostate cancer radiotherapy treatment

12. Did you delay radical prostatectomy for prostate cancer patients as a result of COVID-19?
a. Yes
b. No
c. Partially (please specify:)
d. N/A (please specify:)

13. If yes, have you cleared your radical prostatectomy backlog?
a. Yes
b. No
c. N/A – We did not delay radical prostatectomy for prostate cancer patients

14. To address your backlog did or are you using a protocol to risk stratify patients and prioritise patients with high-risk and locally advanced prostate cancer for treatment within 3 months?
a. Yes
b. No
c. No, we did not have a sufficient backlog to require patient prioritisation

15. Does your protocol apply to new patients with high-risk and locally advanced prostate cancer with the intention to radically treat them within 3 months of diagnosis?
a. Yes
b. No
c. N/A - We do not have a protocol for patient prioritisation

16. Do you have prostate cancer Personalised Stratified Follow Up (PSFU) protocols in place?
a. Yes
b. No
c. We are in the process of developing PSFU protocols

17. If Yes, do you have a digital remote monitoring system in place for follow up?
a. Yes (Please specify the name of the system used: e.g My Medical Record, Patient Knows Best)
b. No

18. If no, do you plan to implement a digital remote monitoring system for follow up?
a. Yes - (Please specify the name of the system you plan to implement: e.g My Medical Record, Patient Knows Best)
b. No

19. Which of the following criteria are part of your follow up protocols? (please mark all that apply:)
a. Patients have access to a Support Worker who acts as their key worker for the duration of their follow up care.
b. Patients have access to an online patient service that allows them to check test results, complete assessments, view patient information and message their clinical team.
c. Patients attend a 4-hour supported self-management workshop with a group of 8 to 10 men to develop knowledge, skills and confidence to self-manage their condition
d. Patients do not need to attend routine appointments unless an issue arises.

Freedom of Information Requests

Thank you for your request under the Freedom of Information (FOI) Act 2000 that was received by Mid and South Essex NHS Foundation Trust today. This is an automated response to confirm receipt of your email.

Mid and South Essex NHS Foundation Trust (MSEFT), which was formed on 1 April 2020 by merger of Mid Essex Hospital Services NHS Trust, Basildon and Thurrock University Hospitals NHS Foundation Trust and Southend University Hospital NHS Foundation Trust, is now responsible for all Freedom of Information requests concerning the three former trusts.

The national standard for responding to FOI requests is 20 working days from receipt.

Kind regards

Nicola Frost
Freedom of Information Manager – MSE Group
Corporate Governance & Membership Services
Mid and South Essex NHS Foundation Trust
Southend University Hospital, Prittlewell Chase, Westcliff-on-Sea, Essex SS0 0RY
Tel: 01702 435555
Email: [email address]<mailto:[email address]>

===============================================================

This email has been sent by Southend University Hospital NHS Foundation Trust email security gateway. The views expressed by the author may not necessarily reflect the views or policies of the Trust.

This email has been processed to remove any known threats or known malicious content. However, you do also need to validate this email and any attachments to it for threats or malicious content, as we can take no responsibility for any malicious content that might be transferred by way of this email.

We do not accept or send emails larger than 30MB. Details of all emails are archived for a period of time for auditing and security purposes.

Information within this message, including replies and forwarded copies subsequently transmitted (which may contain alterations), and any attachments may contain confidential and privileged information, if you are not the intended recipient please accept our apologies; do not disclose, copy or distribute information in this e-mail or take any action in reliance on its contents: to do so is strictly prohibited and may be unlawful. If you have received this message by mistake please reply to inform us before deleting it and destroying any copies. Content of emails received by this Trust will be subject to disclosure under the Freedom of Information Act 2000 and confidential information must be handled in accordance with the Data Protection Act 2018. Unless the information is legally exempt from disclosure, confidentiality of this e-mail and your reply cannot be guaranteed.

Dear Mid and South Essex NHS Foundation Trust,

As you have passed the date for submission we are just emailing a gentle reminder that we would really appreciate a response from yourselves on the above FOI request. We understand this is a difficult time and resources are limited.
Your response will be an integral part of our research on the impact of Covid-19 on prostate cancer diagnosis, treatment, and support. We are undertaking this research to ensure all men have access to the best possible care during this time so it is vital that we obtain as many responses as possible.

We look forward to hearing from you.

Yours faithfully,

Thomas Harding

Freedom of Information Requests

Thank you for your request under the Freedom of Information (FOI) Act 2000 that was received by Mid and South Essex NHS Foundation Trust (MSEFT) today. This is an automated response to confirm receipt of your email.

Mid and South Essex NHS Foundation Trust, which was formed on 1 April 2020 by merger of Mid Essex Hospital Services NHS Trust, Basildon and Thurrock University Hospitals NHS Foundation Trust and Southend University Hospital NHS Foundation Trust, is now responsible for all Freedom of Information requests concerning the three former trusts.

You may be aware that the national standard for responding to FOI requests is 20 working days from receipt. However due to the ongoing COVID-19 pandemic the NHS is under significant pressure at present. As a result, your FOI request is likely to take longer to fulfil than normal. I am sorry that we are not yet able to provide you with a target date for response.
If you have any concerns in this regard, please contact us. You also have the right to complain about the handling of your FOI request to the Information.
The Information Commissioner can be contacted at:
The Information Commissioner’s Office
Wycliffe House
Water Lane
Wilmslow
Cheshire. SK9 5AF
Telephone: 0303 123 1113 or 01625 545 700
Web Address: https://ico.org.uk/your-data-matters/off...

Kind regards

Nicola Frost
Freedom of Information Manager – MSE Group
Corporate Governance & Membership Services
Mid and South Essex NHS Foundation Trust
Basildon University Hospital, Nethermayne, Basildon, Essex, SS16 5NL
Telephone: 01268 593631
Email: [email address]<mailto:[email address]>

===============================================================

This email has been sent by Southend University Hospital NHS Foundation Trust email security gateway. The views expressed by the author may not necessarily reflect the views or policies of the Trust.

This email has been processed to remove any known threats or known malicious content. However, you do also need to validate this email and any attachments to it for threats or malicious content, as we can take no responsibility for any malicious content that might be transferred by way of this email.

We do not accept or send emails larger than 30MB. Details of all emails are archived for a period of time for auditing and security purposes.

Information within this message, including replies and forwarded copies subsequently transmitted (which may contain alterations), and any attachments may contain confidential and privileged information, if you are not the intended recipient please accept our apologies; do not disclose, copy or distribute information in this e-mail or take any action in reliance on its contents: to do so is strictly prohibited and may be unlawful. If you have received this message by mistake please reply to inform us before deleting it and destroying any copies. Content of emails received by this Trust will be subject to disclosure under the Freedom of Information Act 2000 and confidential information must be handled in accordance with the Data Protection Act 2018. Unless the information is legally exempt from disclosure, confidentiality of this e-mail and your reply cannot be guaranteed.

1 Atodiad

Dear Mr Harding

Thank you for your email. I can confirm the Trust responded to you request on 28.10.2020, please find copy attached.

Please be advised that Basildon and Thurrock University Hospitals NHS Foundation Trust (BTUH) Southend University Hospital NHS Foundation Trust (SHUT) and Mid Essex Hospital Services NHS Trust (MEHT) ceased to exist on 31 March 2020.

Mid and South Essex NHS Foundation Trust (MSEFT), which was formed on 1 April 2020 by merger of Mid Essex Hospital Services NHS Trust, Basildon and Thurrock University Hospitals NHS Foundation Trust and Southend University Hospital NHS Foundation Trust, is now responsible for all Freedom of Information requests concerning the three former trusts.

The Freedom of Information address for Mid and South Essex NHS Foundation Trust is [email address]. All future requests should be sent to that address, from which all responses to new requests will be sent.

Kind regards

Nicola Frost
Freedom of Information Manager – MSE Group
Corporate Governance & Membership Services
Mid and South Essex NHS Foundation Trust
Basildon University Hospital, Nethermayne, Basildon, Essex, SS16 5NL
Telephone: 01268 593631

Email [email address]

dangos adrannau a ddyfynnir

Nid ydym yn gwybod a yw'r ymateb mwyaf diweddar i'r cais hwn yn cynnwys gwybodaeth neuai peidio - os chi ywThomas Harding mewngofnodwch a gadael i bawb wybod.